RESEARCH

Reimagining the pharma landscape with design thinking

July 29, 2021

As pharma companies strive for increased commercial success the customer-centric focus can get lost in the adoption of new commercial endeavours. As a result, many have been looking toward the world of design as a way of enhancing their customer engagement and accelerating their position in the market.

Spotlight

Merck Group

Not intended for US & CA visitors. At the biopharma business of Merck, we have an enduring commitment and focus in our specialist therapeutic areas of oncology, neurodegenerative diseases, fertility and endocrinology, along with rheumatology as an emerging area of expertise. We also provide a portfolio of cardiometabolic care and general medicine products, especially in emerging markets where patient need remains high.

OTHER WHITEPAPERS
news image

Non-Destructive Hardness Testing

whitePaper | November 15, 2018

Tablet hardness testing plays an important role in pharmaceutical product development and quality control. In the race to streamline tablet hardness analysis, Advantest combines speed, simplicity and increased the precision with innovative and non-destructive terahertz (THz) metrology.

Read More
news image

Pharma's Shifting Paradigm in Indian Becoming multi- channel market

whitePaper |

To date / the Indian pharma market has been dominated by the trade/retail segment which has contributed up to 85% of the market value. This is unlike most mature markets globally which usually operate in a multi-channeled business model involving not only trade out late but also hospitals, over-the-counter and retail chain.

Read More
news image

CROs and other outsourced pharmaceutical support services

whitePaper |

I n recent years, biopharmaceutical companies large and small have become increasingly reliant on the contract research organisation (CRO) sector and other clinical services specialists to provide research services across the breadth of their R&D operations. The fi nancial crisis had a signifi cant impact on CRO companies, with sponsors scaling back trial programmes, particularly in the early-stage segment covering preclinical activities and Phase I trials.

Read More
news image

Life Sciences Manufacturing and Quality: The New Path to Performance

whitePaper | September 11, 2017

Life Sciences companies are attempting to improve compliance and manufacturing efficiency while they drive to grow revenue and margins. However, current market conditions are creating substantial headwinds to attaining these targets. S

Read More
news image

Chemistry for Better Health

whitePaper | February 11, 2017

The annual Chemical Sciences and Society Summit (CS3) brings together the best minds in chemical science research from around the world and challenges them to propose innovative solutions for society’s most pressing needs in the areas of health, food, energy, and the environment. This unique event boasts an innovative format, aiming to set the course of international science, and rotates each year among the participating nations.

Read More
news image

What does the road to 2020 look like for Pharma with digital?

whitePaper |

Featuring the views and experiences of industry experts from inside and outside of pharma & healthcare, this series of four white papers from PharmiWeb Solutions looks at how pharma can make the right decisions about the technologies, devices and skills necessary to develop effective and measurable digital strategies. This will be the key to gaining competitive advantage – from now, to 2020, and beyond.

Read More

Spotlight

Merck Group

Not intended for US & CA visitors. At the biopharma business of Merck, we have an enduring commitment and focus in our specialist therapeutic areas of oncology, neurodegenerative diseases, fertility and endocrinology, along with rheumatology as an emerging area of expertise. We also provide a portfolio of cardiometabolic care and general medicine products, especially in emerging markets where patient need remains high.

Events